Aldeyra Therapeutics, Inc. (137)
Market Open
23 Oct, 07:57 PM
XSTU 
€
0. 56
+0
+0.8929%
€
- Market Cap
- P/E Ratio
- Div Yield
1,000 Volume
- Eps
€ 0.56
Previous Close Want to track 137 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
137 Earnings Reports FAQ
What is the earnings per share (EPS) for 137?
EPS data for 137 is currently not available, as Aldeyra Therapeutics, Inc has not reported recent earnings.
What is the company's earnings growth rate?
Aldeyra Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Aldeyra Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Aldeyra Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 137 at this time, as Aldeyra Therapeutics, Inc has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
